807 related articles for article (PubMed ID: 28916614)
21. [Genetic architecture of amyotrophic lateral sclerosis and frontotemporal dementia : Overlap and differences].
Synofzik M; Otto M; Ludolph A; Weishaupt JH
Nervenarzt; 2017 Jul; 88(7):728-735. PubMed ID: 28573364
[TBL] [Abstract][Full Text] [Related]
22. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
[TBL] [Abstract][Full Text] [Related]
23. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
24. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
26. Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia.
Gagliardi D; Costamagna G; Taiana M; Andreoli L; Biella F; Bersani M; Bresolin N; Comi GP; Corti S
Ageing Res Rev; 2020 Dec; 64():101172. PubMed ID: 32971256
[TBL] [Abstract][Full Text] [Related]
27. SnapShot: Genetics of ALS and FTD.
Guerreiro R; Brás J; Hardy J
Cell; 2015 Feb; 160(4):798-798.e1. PubMed ID: 25679767
[TBL] [Abstract][Full Text] [Related]
28. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
[TBL] [Abstract][Full Text] [Related]
29. Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Hao Z; Wang R; Ren H; Wang G
Neurosci Bull; 2020 Sep; 36(9):1057-1070. PubMed ID: 32860626
[TBL] [Abstract][Full Text] [Related]
30. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
[TBL] [Abstract][Full Text] [Related]
31. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
[TBL] [Abstract][Full Text] [Related]
32. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
[TBL] [Abstract][Full Text] [Related]
33. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.
Baradaran-Heravi Y; Van Broeckhoven C; van der Zee J
Neurobiol Dis; 2020 Feb; 134():104639. PubMed ID: 31626953
[TBL] [Abstract][Full Text] [Related]
34. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD.
Tang X; Toro A; T G S; Gao J; Chalk J; Oskarsson B; Zhang K
Mol Neurodegener; 2020 Jun; 15(1):34. PubMed ID: 32513219
[TBL] [Abstract][Full Text] [Related]
35. All in the Family: Repeats and ALS/FTD.
Pattamatta A; Cleary JD; Ranum LPW
Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
[TBL] [Abstract][Full Text] [Related]
36. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
Gitler AD; Tsuiji H
Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
[TBL] [Abstract][Full Text] [Related]
37. Synaptic dysfunction in amyotrophic lateral sclerosis/frontotemporal dementia: Therapeutic strategies and novel biomarkers.
Krishnamurthy K; Pasinelli P
J Neurosci Res; 2021 Jun; 99(6):1499-1503. PubMed ID: 33729613
[No Abstract] [Full Text] [Related]
38. Frontotemporal dementia, Parkinsonism and lower motor neuron involvement in a patient with C9ORF72 expansion.
Luigetti M; Quaranta D; Conte A; Piccininni C; Lattante S; Romano A; Silvestri G; Zollino M; Sabatelli M
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Jan; 14(1):66-9. PubMed ID: 22708871
[TBL] [Abstract][Full Text] [Related]
39. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
DeJesus-Hernandez M; Mackenzie IR; Boeve BF; Boxer AL; Baker M; Rutherford NJ; Nicholson AM; Finch NA; Flynn H; Adamson J; Kouri N; Wojtas A; Sengdy P; Hsiung GY; Karydas A; Seeley WW; Josephs KA; Coppola G; Geschwind DH; Wszolek ZK; Feldman H; Knopman DS; Petersen RC; Miller BL; Dickson DW; Boylan KB; Graff-Radford NR; Rademakers R
Neuron; 2011 Oct; 72(2):245-56. PubMed ID: 21944778
[TBL] [Abstract][Full Text] [Related]
40. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
Ji AL; Zhang X; Chen WW; Huang WJ
J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
